Chemed Surpasses Expectations with Strong Q2 | Business and Finance News

Chemed Corporation just smashed Q2 2026 earnings, raking in $673.3 million—up 8.8% year-over-year—and blew past profit expectations. With dual powerhouses in hospice care (VITAS) and home services (Roto-Rooter), the company’s unique blend of life-stage essentials is paying off. Revenue momentum’s back, operating margins jumped from 11% to over 13%, and full-year EPS guidance just got upgraded. Sales held steady, but stronger margins and a revenue beat signal Chemed’s turning the corner—solid, efficient, and on track for a stellar year. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/752ac17da2ff649c